About Tabbetha Dobbins
Tabbetha Dobbins is a director at Sentrimed.
Tabbetha Dobbins first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Tabbetha Dobbins in the role, so the role may have started earlier or lasted longer.
Sentrimed, Inc.
Director
2024 – 2026 · Mullica Hill, NJ
Develops oral cancer treatments for people with head and neck cancer.
Key Colleagues at Startups
The people Tabbetha Dobbins works with at each company, as listed on that company's latest Form D.
Sentrimed, Inc. · Form D, May 13, 2026
AR
Arye Rosen
Vice President
JG
Jack Goldberg
Chief Medical Officer and director
MY
Mari Yin
Treasurer and director
GG
Gary Goldberg
Founder and Chief Science Officer
WR
William Ragatz
President and CEO, director
CL
Christopher Leonard
Secretary
BG
Bradley Galer
Director